Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

BACKGROUND/AIMS: We compared the efficacies of entecavir (ETV) plus tenofovir (TDF) and ETV plus adefovir (ADV) in chronic hepatitis B (CHB) patients with genotypic resistance to lamivudine (LAM) who showed a suboptimal response to LAM and ADV combination therapy. METHODS: We reviewed 63 CHB patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jung Gil, Park, Soo Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612285/
https://www.ncbi.nlm.nih.gov/pubmed/26523269
http://dx.doi.org/10.3350/cmh.2015.21.3.242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612285/
https://www.ncbi.nlm.nih.gov/pubmed/26523269
http://dx.doi.org/10.3350/cmh.2015.21.3.242

Ejemplares similares